piracetam has been researched along with Cherry Red Spot Myoclonus Syndrome in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam can suppress sialidosis-related myoclonus but its effects on cerebral metabolism warrant elucidation." | 1.39 | Functional neuroimages of cortical myoclonus altered by levetiracetam in a patient with sialidosis. ( Chen, KF; Lai, SC; Lu, CS; Lu, MK; Tsai, CH; Wu, YC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, KF | 1 |
| Lai, SC | 1 |
| Wu, YC | 1 |
| Lu, CS | 1 |
| Lu, MK | 1 |
| Tsai, CH | 1 |
1 other study available for piracetam and Cherry Red Spot Myoclonus Syndrome
| Article | Year |
|---|---|
Functional neuroimages of cortical myoclonus altered by levetiracetam in a patient with sialidosis.
Topics: Adult; Cerebral Cortex; Humans; Levetiracetam; Male; Mucolipidoses; Myoclonus; Neuroimaging; Piracet | 2013 |